Delivery Order SPE2DB20D1102-SPE2DB25FC6TH
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens, with a ceiling value of $8,959.80. This is a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award utilizes no set-aside designation, indicating it was competitively awarded. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $2,377.80 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on July 25, 2025, with completion targeted for July 28, 2025. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This is a firm fixed price delivery order with no set-aside designation, awarded competitively as part of the company's broader pharmaceutical supply relationship with the federal government. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 18, 2025, with completion targeted for August 19, 2025. This delivery order represents a firm fixed-price contract with no set-aside designation, issued under a competitive procurement process. The award is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens with a ceiling value of $1,735.26. This firm fixed-price delivery order, which must be completed by August 11, 2025, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement. The contract carries no set-aside designation, indicating it was competitively awarded....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for supply of Trulicity 0.75 mg/0.5 ml pens valued at $1,184.18, with completion scheduled for August 12, 2025. This competitive award, issued without set-aside provisions, represents a firm fixed-price delivery order for the diabetes medication to support federal healthcare requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens valued at $4,911.97 on August 25, 2025. This competitively awarded, firm fixed-price contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor vehicle extending through December 2026. The delivery order is set to be completed...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 28, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens valued at $1,226.40. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 29, 2025, and carries no set-aside designation, indicating it was competitively awarded. This delivery order represents a single...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pens valued at $3,049.11 with completion targeted for September 15, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The performance location is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pens valued at $2,795.69 with a completion date of September 24, 2025. This competitive award, issued under firm fixed pricing, represents a single delivery order transaction for diabetes medication to support federal medical supply requirements. The contract carries no set-aside designation and will be performed at AmerisourceBergen's Corporate...
- The Defense Logistics Agency awarded a $5,191.88 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens with a completion date of July 25, 2025. This is a firm fixed price, non-set-aside contract with performance in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00...
- SPE2DB20D1102Indefinite Delivery Contract
- SPE2DB20D1102-SPE2DB25FC6THDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens in 0.5 mL quantities, with a ceiling value of $2,252.25. This is a firm fixed price delivery order with an ultimate completion date of August 14, 2025, and will be performed at the vendor's facility in Conshohocken, Pennsylvania. The award utilized no set-aside designation, indicating competitive procurement. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical vendor supplying pharmaceutical products and medical supplies to military and veteran healthcare systems. The broader IDC vehicle enables the company to provide a comprehensive range of medications and medical commodities, including specialty drugs, vaccines, and medical devices across multiple therapeutic domains, supporting the Defense Health Agency and other government healthcare systems globally. As a leading pharmaceutical prime vendor for the DLA Medical Supply Chain, AmerisourceBergen has demonstrated consistent capability to meet federal procurement requirements through open competition across delivery orders ranging substantially in value.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 8/13/25 |